T1D-Plus study with Dexcom

A Contract Award Notice
by CARDIFF UNIVERSITY

Source
Find a Tender
Type
Contract ()
Duration
not specified
Value
£76K
Sector
MISCELLANEOUS
Published
19 Jan 2026
Delivery
not specified
Deadline
n/a

Related Terms

Location

Geochart for 1 buyers and 1 suppliers

1 buyer

1 supplier

Description

T1D-Plus trial is a randomised, adaptive, open label, parallel group, multi-centre Platform trial in adults with newly diagnosed type 1 diabetes). The T1D Plus trial, funded by JDRF, sponsored by CU, started on 30th September 2022, led by Colin Dayan. Since that time, additional arms of the trial have been funded by separate grants from the Helmsley Charitable Trust and JDRF Australia. Funding was agreed in Dec 2023. An endpoint in the trial is the recording of glucose levels by a continuous glucose monitoring device. These devices are marketed by different companies with different specifications.

Award Detail

1 Dexcom (Edinburgh)
  • T1D-Plus study with Dexcom
  • Reference: 1
  • Value: £76,000

CPV Codes

  • None found

Other Information

** PREVIEW NOTICE, please check Find a Tender for full details. **

Reference

  • ocds-h6vhtk-060896
  • FTS 004306-2026

Domains